Differences Between EU Annex 15 and FDA Validation Expectations
Differences Between EU Annex 15 and FDA Validation Expectations Understanding the Differences Between EU Annex 15 and FDA Validation Expectations Pharmaceutical manufacturers operating in the US, UK, and EU must navigate a complex regulatory landscape when establishing and maintaining their process validation and cleaning validation programs to ensure GMP compliance. Two of the principal guidance…
Read More “Differences Between EU Annex 15 and FDA Validation Expectations” »